Speaking Engagements
 
Email Page
American Conference Institute's Sixth Annual Biosimilars Conference
June 1, 2015

Axinn Partner Chad Landmon participated in the panel discussion, "The Road Ahead: Minimizing the Uncertainty Surrounding FDA Standards for Interchangeability and Biosimilarity," at the American Conference Institute's Sixth Annual Summit on Biosimilars on June 1, 2015 in New York.